BNC Korea Co., Ltd. (256840.KQ)

KRW 4160.0

(-1.42%)

Revenue Summary of BNC Korea Co., Ltd.

  • BNC Korea Co., Ltd.'s latest annual revenue in 2023 was 80.99 Billion KRW , up 91.47% from previous year.
  • BNC Korea Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 22.71 Billion KRW , up 31.92% from previous quarter.
  • BNC Korea Co., Ltd. reported a annual revenue of 42.3 Billion KRW in annual revenue 2022, up 67.55% from previous year.
  • BNC Korea Co., Ltd. reported a annual revenue of 25.24 Billion KRW in annual revenue 2021, up 29.89% from previous year.
  • BNC Korea Co., Ltd. reported a quarterly revenue of 17.22 Billion KRW for 2024 Q1, down -26.58% from previous quarter.
  • BNC Korea Co., Ltd. reported a quarterly revenue of 80.99 Billion KRW for 2023 FY, up 91.47% from previous quarter.

Annual Revenue Chart of BNC Korea Co., Ltd. (2023 - 2016)

Historical Annual Revenue of BNC Korea Co., Ltd. (2023 - 2016)

Year Revenue Revenue Growth
2023 80.99 Billion KRW 91.47%
2022 42.3 Billion KRW 67.55%
2021 25.24 Billion KRW 29.89%
2020 19.43 Billion KRW 10.01%
2019 17.66 Billion KRW 5.92%
2018 16.68 Billion KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Revenue Comparison of BNC Korea Co., Ltd.

Name Revenue Revenue Difference
HLB Pharmaceutical Co., Ltd 135.95 Billion KRW 40.422%
CMG Pharmaceutical Co., Ltd. 93.9 Billion KRW 13.747%
Celltrion Pharm, Inc. 388.79 Billion KRW 79.167%
Huons Global Co., Ltd. 758.37 Billion KRW 89.32%
DongKook Pharmaceutical Co., Ltd. 730.99 Billion KRW 88.92%
Enzychem Lifesciences Corporation 76.03 Billion KRW -6.521%
Humedix Co., Ltd. 152.27 Billion KRW 46.808%
Boditech Med Inc. 134.21 Billion KRW 39.653%
EuBiologics Co., Ltd. 69.36 Billion KRW -16.769%
FutureChem Co.,Ltd 13.96 Billion KRW -479.878%
Huons Co., Ltd. 552 Billion KRW 85.327%
AptaBio Therapeutics Inc. 323.86 Million KRW -24909.351%